ADVERTISEMENT
Videos
The First-in-Human Trial for the Valiant Mona LSA Stent Graft System: An Interview With Frank R. Arko, MD
02/18/2014
The Valiant Mona LSA branch thoracic stent graft system (Medtronic) was evaluated
in a first-in-human study being conducted under the US Food and Drug Administration (FDA) Innovation Pathway early feasibility pilot program. Data from the study were presented at the 2013 VEITHsymposium. In the video below, study investigator Frank Arko, MD, discusses the study and the data presented.
